Skip to Main Content
Contribute Try STAT+ Today

WASHINGTON — Two key federal health officials are pitching a new branch of the National Institutes of Health that would take on higher-risk research than the rest of the agency, in a bid to “transform important areas of medicine and health.”

The new vision, from Biden science adviser Eric Lander and NIH Director Francis Collins, fleshes out new details for an initiative President Biden pitched as a new research agency intended to “end cancer as we know it.” Their plan would push the new agency to focus on far broader goals, like inventing smartwatches that continuously monitor blood pressure, developing vaccines that can be designed and approved within 100 days, and finding new techniques for tracking the impact of Alzheimer’s disease on the brain. The agency will also focus on eliminating health disparities, they said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment